Quality standard
Quality statement 5: Assessing for psoriatic arthritis
Quality statement 5: Assessing for psoriatic arthritis
Quality statement
People with psoriasis having treatment are offered an annual assessment for psoriatic arthritis.
Rationale
Psoriatic arthritis is a form of arthritis that is seen in people with psoriasis. This condition is often undiagnosed, leading to poorer long-term outcomes such as damage to joints and functional ability. Annual assessment for the condition (which may form part of a holistic review of response to treatment and disease severity and impact) could help to identify people with psoriatic arthritis earlier, so that treatment can be planned accordingly and before joint damage occurs.
Quality measures
The following measures can be used to assess the quality of care or service provision specified in the statement. They are examples of how the statement can be measured, and can be adapted and used flexibly.
Structure
Evidence of local arrangements for people with psoriasis having treatment to receive an annual assessment for psoriatic arthritis.
Data source: Local data collection.
Process
Proportion of people with psoriasis having treatment who receive an annual assessment for psoriatic arthritis.
Numerator – the number of people in the denominator who receive an annual assessment for psoriatic arthritis.
Denominator – the number of people with psoriasis having treatment.
Data source: Local data collection.
What the quality statement means for different audiences
Service providers ensure that systems are in place for people with psoriasis having treatment to be offered an annual assessment for psoriatic arthritis.
Healthcare practitioners ensure that people with psoriasis having treatment are offered an annual assessment for psoriatic arthritis.
Commissioners ensure that they commission services for people with psoriasis having treatment to be offered an annual assessment for psoriatic arthritis.
People with psoriasis having treatment are offered an annual assessment for psoriatic arthritis (a type of joint disease).
Source guidance
Psoriasis: assessment and management. NICE guideline CG153 (2012, updated 2017), recommendations 1.2.2.1 and 1.2.2.2
Definitions of terms used in this quality statement
People with psoriasis having treatments
People with psoriasis having treatments such as active topical therapy (for example, corticosteroids), phototherapy or systemic therapy should be offered an annual assessment for psoriatic arthritis.
The Psoriasis Epidemiological Screening Tool (PEST) can be used to help assess for psoriatic arthritis, although it does not detect axial arthritis or inflammatory back pain and is not validated in children. However, children should still be clinically assessed for psoriatic arthritis.